Serial infusions of low-dose ketamine for major depression. - Wikidata - awgldk - TriplyDB

Serial infusions of low-dose ketamine for major depression.

Serial infusions of low-dose ketamine for major depression.

http://www.wikidata.org/entity/Q34648663

about

Intravenous sub-anesthetic ketamine for perioperative analgesia Treatment-Resistant Major Depression: Rationale for NMDA Receptors as Targets and Nitrous Oxide as Therapy Potential of Glutamate-Based Drug Discovery for Next Generation Antidepressants Ketamine, sleep, and depression: current status and new questions Ketamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacy A brief history of the development of antidepressant drugs: from monoamines to glutamate Use of repeated intravenous ketamine therapy in treatment-resistant bipolar depression with suicidal behaviour: a case report from Spain.Effects of striatal ΔFosB overexpression and ketamine on social defeat stress-induced anhedonia in mice.Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds.Post-electroconvulsive therapy recovery and reorientation time with methohexital and ketamine: a randomized, longitudinal, crossover design trial.Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review.Ketamine and Beyond: Investigations into the Potential of Glutamatergic Agents to Treat Depression.Does ketamine have anti-suicidal properties? Current status and future directions Ketamine as a promising prototype for a new generation of rapid-acting antidepressants.Molecular recognition of ketamine by a subset of olfactory G protein-coupled receptors.Ketamine for depression: evidence, challenges and promise Novel Glutamatergic Treatments for Severe Mood Disorders."Does Ketamine Have Rapid Anti-Suicidal Ideation Effects?"Effects of Low-Dose and Very Low-Dose Ketamine among Patients with Major Depression: a Systematic Review and Meta-Analysis.Ninety-six hour ketamine infusion with co-administered clonidine for treatment-resistant depression: A pilot randomised controlled trial.Group II mGlu receptor antagonist LY341495 enhances the antidepressant-like effects of ketamine in the forced swim test in rats Current Trends in Identifying Rapidly Acting Treatments for Depression Ketamine as antidepressant? Current state and future perspectives.Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder Synaptic Plasticity, Metaplasticity and Depression.Ketamine rapidly relieves acute suicidal ideation in cancer patients: a randomized controlled clinical trial.The emerging role of dopamine-glutamate interaction and of the postsynaptic density in bipolar disorder pathophysiology: Implications for treatment.A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes.Multistage drug effects of ketamine in the treatment of major depression.The promise of ketamine for treatment-resistant depression: current evidence and future directions.The use of ketamine as an antidepressant: a systematic review and meta-analysis.Strategies to mitigate dissociative and psychotomimetic effects of ketamine in the treatment of major depressive episodes: a narrative review.Targeting glutamate signalling in depression: progress and prospects.Risks Associated with Misuse of Ketamine as a Rapid-Acting Antidepressant.KETAMINE FOR TREATMENT-RESISTANT UNIPOLAR AND BIPOLAR MAJOR DEPRESSION: CRITICAL REVIEW AND IMPLICATIONS FOR CLINICAL PRACTICE.KETAMINE: A POTENTIAL RAPID-ACTING ANTISUICIDAL AGENT?Ketamine for Treatment of Suicidal Ideation and Reduction of Risk for Suicidal Behavior.Mood Therapeutics: Novel Pharmacological Approaches for Treating Depression Symptomatology and predictors of antidepressant efficacy in extended responders to a single ketamine infusion.

P2860

Q26747577-0AD1F69A-9307-4459-8879-413C77E1CE9E Q26773084-A9293642-9E89-4A53-ACB3-971C0F3EEAD9 Q26782274-241B6000-DCBC-4B54-A744-6C4E242D1438 Q26828564-1D94BB72-FF6F-485B-A546-44839C2A2A43 Q27024227-9F524D07-5263-47F3-AE92-C1FE92320DD6 Q27028050-148E41C1-54DB-432B-8AD5-9A714A83E0D4 Q33693374-0E5AEADE-D6B4-4427-89E7-E2D2325F562A Q33864745-4FD2EAFD-7E65-4904-AD20-C4593CB0A212 Q33874459-15C9B4C6-63BE-4A76-BF29-15EB2801E4DC Q34381555-5DF1FDBB-5A0E-4189-AD8A-EEE410356832 Q34444632-6F8B397A-5BBF-4418-9B9F-3CE69FC1A354 Q34475595-DBB19716-0926-472D-AA34-6E59187A2F72 Q34551188-D21CB70A-596A-4400-BFFC-846B219DF279 Q35235620-DF194B50-5A7B-4C60-B66C-E4C5D3644B9C Q35547495-46D85DAF-3605-4D9C-A0A7-F78738FF7462 Q35903269-BDA825DC-3E92-46E2-84DF-E4931FE82BF6 Q36118741-64B61BAF-0783-440E-B247-E527B3A45BD8 Q36498659-BA80B078-6893-4594-8842-BA8074CE2B7E Q36603490-53CB1214-8BFC-495E-9D75-DF690B80A455 Q36852411-5781156A-78A6-48CC-A1D3-F9D1D951826F Q36998808-BB6426D4-7A2A-41B3-9B43-C301A131A1A3 Q37067121-F3F66B62-C0D3-4BAE-B902-573A34A7977B Q37210886-8966BA09-5B6F-4FF6-AD73-923B35AB8BE4 Q37559823-2BCCD850-0CB4-4CCE-9291-BCDCF5C94149 Q37668014-FA6AD23A-9A8E-43B8-AABC-0C1B6E86A2C7 Q37668039-BE768F7E-4651-4FF3-99EF-5A34146F9A95 Q37709284-2866DBF5-FE86-46D1-8475-35B1E48F427B Q38189780-DAD628F5-FAC4-46A6-87C2-D49B449DCBF5 Q38227967-34E69AF4-F2BA-46B3-AC8E-C01AEC9598A4 Q38248776-53880A00-E951-49D9-80D4-11B2B09B8D79 Q38343315-39972E09-9F35-492D-AF8E-6FB3CACDAA7F Q38408563-8DE51993-C373-4287-84D7-6FFC65F41404 Q38692317-D53A21E2-14DA-4133-B59F-93020D5DAA58 Q38743867-037E1D2C-2B5C-4D53-BCE8-4C747E64F23B Q38791739-9D239174-CE13-4E69-ADA9-3E399475E559 Q38803429-001D1016-C869-4E83-95A2-57353EB65757 Q38809056-28F7C38C-30D2-4F42-A8E3-71D8F7A9D103 Q38837851-4BA2AE6F-1D36-4227-8D43-51ACA13ACBE4 Q38990885-26DEE4A8-AF89-4408-9A81-9C0034F412BB Q39006965-F1D5124E-0C85-4B98-AC91-A043F29F6DC6

P2860

Serial infusions of low-dose ketamine for major depression.

http://www.wikidata.org/entity/Q34648663

description

2013 nî lūn-bûn

@nan

2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Serial infusions of low-dose ketamine for major depression.

@ast

Serial infusions of low-dose ketamine for major depression.

@en

Serial infusions of low-dose ketamine for major depression.

@nl

type

label

Serial infusions of low-dose ketamine for major depression.

@ast

Serial infusions of low-dose ketamine for major depression.

@en

Serial infusions of low-dose ketamine for major depression.

@nl

prefLabel

Serial infusions of low-dose ketamine for major depression.

@ast

Serial infusions of low-dose ketamine for major depression.

@en

Serial infusions of low-dose ketamine for major depression.

@nl

P1433

Q34648663-872D774B-A841-41AD-B7BE-F115E6FD6B7A

P1476

Q34648663-3E5D1180-EF8F-44A8-B86F-F12DA7757A73

P2093

Q34648663-1940A9DA-4FA3-4517-9FD2-D4F3ADB4109D

Q34648663-3E6E16A6-7904-42E6-AF9C-D55A71DA9B49

Q34648663-8AD8F237-41A7-4A2A-86D9-68C62D2FD527

Q34648663-91EEA96B-CD6D-41ED-B384-4372373280ED

Q34648663-A04D7575-5534-4D5C-9506-5FE837E0F8FB

Q34648663-B7657D2E-14DF-4099-8244-D469FF561BF1

Q34648663-CD149875-E92F-455A-8BF2-0CB0E3D12D32

Q34648663-E9695522-86C2-4EDF-BEDC-88047A76A718

Q34648663-ED430E99-C66B-4A22-BFD5-40FE5FB4A66A

Q34648663-FB74A45E-8E6E-440E-B278-34DB8E150EBC

P2860

Q34648663-02CE6FFF-DB0D-4BF4-930E-22D22FEBEA32

Q34648663-02FD553C-5593-4353-B973-D05EF5AFA79A

Q34648663-057C9ADF-A011-4C64-A2C1-F07FDECBE945

Q34648663-099C486F-CECF-4924-AAAC-5B592A1D67DB

Q34648663-0A73A23E-0C86-4BCE-9168-B094785D1C4C

Q34648663-2670BE21-C05E-4324-A7C5-30D81DEFFEB5

Q34648663-272D5A0E-6657-4917-A88E-859E695B28B0

Q34648663-35E531C9-D8DF-4F33-B92A-F5F1C0D308A7

Q34648663-382827A7-13DA-453A-8682-41EFE3A64D47

Q34648663-3C9EA10E-6353-4679-B7B6-87B777F059B4

P304

Q34648663-AF29779C-1BA2-4E69-83B0-59BDCA27BD9F

P31

Q34648663-22E10405-D799-4162-B47B-9AF6511CB774

P356

Q34648663-53EA3BB8-A410-483A-92B5-4FF67FBE8CE0

P407

Q34648663-58333AB6-05CF-4221-90E6-47118C5AF071

P433

Q34648663-4324AF9D-BD66-4301-BC3E-CC54382E0C9B

P478

Q34648663-E9F80AF8-FB85-4DF7-B433-55C0F54927E9

P577

Q34648663-A5CD5ACB-B182-4CB2-9AA0-2FAC80CF9C83

P5875

Q34648663-1CA7F28D-66DE-4E46-B1E9-8741A22992DC

P698

Q34648663-ADBC153E-0810-4E6F-934F-9351FEE8EB80

P356

0269881113478283

P1433

Journal of Psychopharmacology

P1476

Serial infusions of low-dose ketamine for major depression.

@en

P2093

Allison J Hanson

http://www.w3.org/2001/XMLSchema#string

Brian A Palmer

http://www.w3.org/2001/XMLSchema#string

Christine W Galardy

http://www.w3.org/2001/XMLSchema#string

Christopher L Sola

http://www.w3.org/2001/XMLSchema#string

Kathryn M Schak

http://www.w3.org/2001/XMLSchema#string

Keith G Rasmussen

http://www.w3.org/2001/XMLSchema#string

Maria I Lapid

http://www.w3.org/2001/XMLSchema#string

Mark A Frye

http://www.w3.org/2001/XMLSchema#string

Matthew J Ritter

http://www.w3.org/2001/XMLSchema#string

Simon Kung

http://www.w3.org/2001/XMLSchema#string

P2860

Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial

A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression

A new depression scale designed to be sensitive to change

Antidepressant effects of ketamine in depressed patients

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

A rating scale for mania: reliability, validity and sensitivity

Anterior cingulate desynchronization and functional connectivity with the amygdala during a working memory task predict rapid antidepressant response to ketamine.

Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression.

Ketamine-induced vesicopathy: a literature review.

Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder

P304

444-450

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0269881113478283

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235689468

http://www.w3.org/2001/XMLSchema#string

P698

23428794

http://www.w3.org/2001/XMLSchema#string